Both in Pharmaceuticals
Damora Therapeutics vs LB Pharmaceuticals
Over the past year DMRA returned −23.1% and LBRX returned −10.8%; their daily moves had a correlation of 0.63.
DMRA −23.1% LBRX −10.8%Growth of $1, one year, split-adjusted
| Metric | DMRA | LBRX |
|---|---|---|
| Price | $21.61 | $39.83 |
| Market cap | $1.33B | $1.28B |
| Today | −1.59% | +0.48% |
| 1 month | +4.6% | +6.8% |
| 6 months | — | +30.2% |
| Year to date | — | +78.9% |
| 1 year | — | +138.5% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $540.5M | $327.8M |
| Dividend yield | — | — |
| Volatility (60d) | — | 53.5% |
| Short % of float | 11.2% | 23.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).